GK921, a transglutaminase inhibitor, strengthens the antitumor effect of cisplatin on pancreatic cancer cells by inhibiting epithelial-to-mesenchymal transition

Authors:

Abstract
No abstract available

This publication has 36 references indexed in Scilit: